跳至主要内容
临床试验/IRCT201111288240N1
IRCT201111288240N1已完成3 期

The effect of intravenous albumin in mortality and morbidity of intracranial hemorrhage; a randomized clinical trial

JondiShapur Ahvaz university of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 83 years(—)
性别
All

入选标准

  • Inclusion Criteria: 1.Primary supratentorial ICH; 2.< 24 hours from symptom onset; 3.Age >18.

排除标准

  • 1.ICH volume < 7 cc; 2.Glasgow Coma Scale < 8; 3.Surgical evacuation anticipated; 4.Pregnancy; 5. Breastfeeding; 6.Hemodynamic instability (SBP < 100 mmHg, > 200 mmHg); 7.Current participation in another experimental treatment protocol; 8.Renal impairment with GFR < 30 or Creatinine > 2.0; 9.History of or known allergy to albumin; 10. History of or known severe allergy to rubber latex; 11.Episode/exacerbation of congestive heart failure (CHF) from any cause in the last 6 months. (An episode of congestive heart failure is any heart failure that required a change in medication, diet or hospitalization); 12.Acute myocardial infarction in the last 6 months; 13.Elevated serum troponin level on admission > 0.1 mcg/L; 14.Known valvular heart disease with CHF in the last 6 months; 15.Known (or in the investigator's judgment) existence of severe aortic stenosis or mitral stenosis; 16.Cardiac surgery involving thoracotomy (e.g., coronary artery bypass graft (CABG), valve replacement surgery) in the last 6 months; 17.Suspicion of aortic dissection on admission; 18.Acute arrhythmia (including any tachy- or bradycardia) with hemodynamic instability on admission (systolic blood pressure < 100 mmHg); 19.Findings on physical examination of any of the following: (1) jugular venous distention (JVP > 4 cm above the sternal angle), (2) 3rd heart sound, (3) resting tachycardia (heart rate > 100/min) attributable to congestive heart failure, (4) abnormal hepatojugular reflux, (5) lower extremity pitting edema attributable to congestive heart failure or without apparent cause, (6) bilateral rales, and/or (7) if a chest x-ray is performed, definite evidence of pulmonary edema, bilateral pleural effusion, or pulmonary vascular redistribution; 20.Current acute or chronic lung disease requiring supplemental chronic or intermittent oxygen therapy; 21.Prosthetic heart valves; 22.Documented left ventricular ejection fraction < 35%.

研究者

发起方
JondiShapur Ahvaz university of Medical Sciences

相似试验

Effect of Albumin in Hemorrhagic Stroke | 临床试验